BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 10515753)

  • 1. Liposomal amphotericin B for fever and neutropenia.
    Wingard JR
    N Engl J Med; 1999 Oct; 341(15):1153; author reply 1154-5. PubMed ID: 10515753
    [No Abstract]   [Full Text] [Related]  

  • 2. Liposomal amphotericin B for fever and neutropenia.
    Winston DJ; Schiller GJ; Territo MC
    N Engl J Med; 1999 Oct; 341(15):1154-5. PubMed ID: 10515755
    [No Abstract]   [Full Text] [Related]  

  • 3. Liposomal amphotericin B for fever and neutropenia.
    Rakita R
    N Engl J Med; 1999 Oct; 341(15):1153-4; author reply 1154-5. PubMed ID: 10515754
    [No Abstract]   [Full Text] [Related]  

  • 4. Liposomal amphotericin B for fever and neutropenia.
    Prentice HG; Kibbler CC
    N Engl J Med; 1999 Oct; 341(15):1152-3; author reply 1154-5. PubMed ID: 10515751
    [No Abstract]   [Full Text] [Related]  

  • 5. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group.
    Walsh TJ; Finberg RW; Arndt C; Hiemenz J; Schwartz C; Bodensteiner D; Pappas P; Seibel N; Greenberg RN; Dummer S; Schuster M; Holcenberg JS
    N Engl J Med; 1999 Mar; 340(10):764-71. PubMed ID: 10072411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liposomal amphotericin B for fever and neutropenia.
    Fischer T; Heussel G; Huber C
    N Engl J Med; 1999 Oct; 341(15):1152; author reply 1154-5. PubMed ID: 10515750
    [No Abstract]   [Full Text] [Related]  

  • 7. Empirical antifungal therapy for persistent fever in patients with neutropenia.
    Chandrasekar PH
    Clin Infect Dis; 2001 Jan; 32(2):320-1. PubMed ID: 11170928
    [No Abstract]   [Full Text] [Related]  

  • 8. A benefit for renal function after early switch to liposomal amphotericin B from conventional formulation in empirical antifungal treatment.
    Isnard F; Tilleul P; Laporte JP; Chevallier P; Pigneux A; Lafuma A; Mahi L; Deray G
    Nephrol Dial Transplant; 2007 Oct; 22(10):3090-1. PubMed ID: 17595189
    [No Abstract]   [Full Text] [Related]  

  • 9. Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia.
    Noel GJ
    J Pediatr; 1999 Sep; 135(3):399. PubMed ID: 10523149
    [No Abstract]   [Full Text] [Related]  

  • 10. Liposomal amphotericin B indicated for empirical therapy.
    AIDS Patient Care STDS; 1997 Dec; 11(6):458-9. PubMed ID: 11361874
    [No Abstract]   [Full Text] [Related]  

  • 11. Liposomal amphotericin B for the treatment of severe fungal infection.
    Michaud D
    Dynamics; 2001; 12(1):17-21. PubMed ID: 11982230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liposomal amphotericin B versus the combination of fluconazole and itraconazole as prophylaxis for invasive fungal infections during induction chemotherapy for patients with acute myelogenous leukemia and myelodysplastic syndrome.
    Mattiuzzi GN; Estey E; Raad I; Giles F; Cortes J; Shen Y; Kontoyiannis D; Koller C; Munsell M; Beran M; Kantarjian H
    Cancer; 2003 Jan; 97(2):450-6. PubMed ID: 12518369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, double-blind comparative trial evaluating the safety of liposomal amphotericin B versus amphotericin B lipid complex in the empirical treatment of febrile neutropenia. L Amph/ABLC Collaborative Study Group.
    Wingard JR; White MH; Anaissie E; Raffalli J; Goodman J; Arrieta A;
    Clin Infect Dis; 2000 Nov; 31(5):1155-63. PubMed ID: 11073745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevention and treatment of invasive mycoses in patients with neutropenia and bone marrow transplantation].
    Burgaleta C
    Rev Clin Esp; 1995 Oct; 195 Suppl 3():31-7. PubMed ID: 9441303
    [No Abstract]   [Full Text] [Related]  

  • 15. Fungal infections in neonates: update on prevention and treatment.
    Kaufman DA
    Minerva Ginecol; 2007 Jun; 59(3):311-29. PubMed ID: 17576407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Voriconazole versus liposomal amphotericin B for empirical antifungal therapy.
    Ullmann AJ; Heussel CP; Cornely OA
    N Engl J Med; 2002 May; 346(22):1745-7; author reply 1745-7. PubMed ID: 12041526
    [No Abstract]   [Full Text] [Related]  

  • 17. Randomized trial of fluconazole versus low-dose amphotericin B in prophylaxis against fungal infections in patients undergoing hematopoietic stem cell transplantation.
    Koh LP; Kurup A; Goh YT; Fook-Chong SM; Tan PH
    Am J Hematol; 2002 Dec; 71(4):260-7. PubMed ID: 12447954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of liposomal amphotericin B in bone marrow transplant.
    Sastry PS; Parikh PM; Kulkarni PS; Bhagwat R; Gadade H
    J Postgrad Med; 2005; 51 Suppl 1():S49-52. PubMed ID: 16519256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Voriconazole versus liposomal amphotericin B in patients with neutropenia and persistent fever.
    Powers JH; Dixon CA; Goldberger MJ
    N Engl J Med; 2002 Jan; 346(4):289-90. PubMed ID: 11807157
    [No Abstract]   [Full Text] [Related]  

  • 20. Early empiric antifungal therapy of infections in neutropenic patients comparing fluconazole with amphotericin B/flucytosine.
    Silling G; Fegeler W; Roos N; Essink M; Büchner T
    Mycoses; 1999; 42 Suppl 2():101-4. PubMed ID: 10865914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.